Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TYSON FOODS, INC.TSN · Entity 3273 | Director | February 07, 2025 | February 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TYSON FOODS, INC.
Report date February 07, 2025 · Filed February 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 131,715.085 |
Reported balance
After 2025-02-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-02-07 · Grant · Acquired 4,228.512 · Balance 131,715.085 F1: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $245,000 as of February 7, 2025, in connection with the Reporting Person's election as a director. Pursuant to the Issuer's Director Compensation Policy, the Reporting Person elected to take this stock award in lieu of a deferred stock award otherwise granted to the Issuer's non-employee directors. F2: Includes 4,237.253 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $245,000 as of February 7, 2025, in connection with the Reporting Person's election as a director. Pursuant to the Issuer's Director Compensation Policy, the Reporting Person elected to take this stock award in lieu of a deferred stock award otherwise granted to the Issuer's non-employee directors.
F2: Includes 4,237.253 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LUMINEX CORP
Report date July 14, 2021 · Filed July 15, 2021
Section 16 reporting ended · disclosed 2021-07-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 75,925 |
Reported balance
After 2021-07-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-07-14 · Disposition to issuer · Disposed 24,443 · Balance 75,925 F1: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share. F2: This total includes 1,001 dividend shares acquired from the Reporting Person's brokerage Dividend Reinvestment Plan as follows: 782 shares corrected on 12/31/20, 87 shares on 01/14/21, 66 shares on 04/15/21, and 66 shares on 07/08/21. F3: This total includes 1,074 dividend equivalent shares acquired from the Issuer as follows: 180 shares on 07/09/20, 267 shares on 10/15/20, 244 shares on 01/14/21, 185 shares on 04/15/21, and 198 shares on 07/08/21. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-07-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-07-14 · Disposition to issuer · Disposed 75,925 · Balance 0 F4: Disposed of pursuant to the Merger Agreement, whereby unvested restricted stock units ("Company RSUs") which were outstanding as of immediately prior to the Effective Time fully vested, and each Company RSU that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share.
F2: This total includes 1,001 dividend shares acquired from the Reporting Person's brokerage Dividend Reinvestment Plan as follows: 782 shares corrected on 12/31/20, 87 shares on 01/14/21, 66 shares on 04/15/21, and 66 shares on 07/08/21.
F3: This total includes 1,074 dividend equivalent shares acquired from the Issuer as follows: 180 shares on 07/09/20, 267 shares on 10/15/20, 244 shares on 01/14/21, 185 shares on 04/15/21, and 198 shares on 07/08/21.
F4: Disposed of pursuant to the Merger Agreement, whereby unvested restricted stock units ("Company RSUs") which were outstanding as of immediately prior to the Effective Time fully vested, and each Company RSU that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes).
Signify Health, Inc.
Report date March 29, 2023 · Filed March 29, 2023
Section 16 reporting ended · disclosed 2023-03-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Long Dog, LLC | 0 |
Last balance in matching sequence
After 2023-03-29 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-03-29 · Conversion · Acquired 1,260,850 · Balance 1,260,850 F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F5: The Reporting Person serves as sole voting member and manager of the LLC. Row 4 · 2023-03-29 · Disposition to issuer · Disposed 1,260,850 · Balance 0 F4: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration. F5: The Reporting Person serves as sole voting member and manager of the LLC. |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-03-29 transaction · row 2
1 source rowRow 2 · 2023-03-29 · Disposition to issuer · Disposed 22,588 · Balance 0 F2: Pursuant to the Merger Agreement, each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. |
| Class B Common StockSEC Table I · non-derivative | IndirectBy Long Dog, LLC | 0 |
Reported balance
After 2023-03-29 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-03-29 · Disposition to issuer · Disposed 1,260,850 · Balance 0 F3: Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled. F5: The Reporting Person serves as sole voting member and manager of the LLC. |
| LLC Units in Cure Aggregator, LLCSEC Table II · derivative / convertible security | IndirectBy Long Dog, LLC | 0 |
Reported balance
After 2023-03-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-29 · Conversion · Disposed 1,260,850 · Balance 0 F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F5: The Reporting Person serves as sole voting member and manager of the LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock.
F2: Pursuant to the Merger Agreement, each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU.
F3: Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled.
F4: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration.
F5: The Reporting Person serves as sole voting member and manager of the LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2025 Filed Feb 11, 2025 16:42 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 4,228.512 | $57.94 | $244,999.99 |
DisclosureSEC source: 0000100493-25-000032 · wk-form4_1739292170.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,715.085 F1 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $245,000 as of February 7, 2025, in connection with the Reporting Person's election as a director. Pursuant to the Issuer's Director Compensation Policy, the Reporting Person elected to take this stock award in lieu of a deferred stock award otherwise granted to the Issuer's non-employee directors. F2 · balance_after: Includes 4,237.253 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 15:25 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 4,374.287 | $52.58 | $230,000.01 |
DisclosureSEC source: 0000100493-24-000039 · wk-form4_1707837937.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,249.32 F1 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $230,000 granted upon their election or re-election as a director. F2 · balance_after: Includes 3,204.7592 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| May 12, 2023 Filed May 16, 2023 17:26 UTC | TYSON FOODS, INC. TSN · Entity 3273 | PurchaseClass A Common Stock | 20,500 | $48.92 | $1,002,802.60 |
DisclosureSEC source: 0000100493-23-000081 · wf-form4_168425798290474.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,670.2738 F1 · price: This is a weighted average price. These shares were purchased in multiple transactions on May 12, 2023 at prices ranging from $48.86 to $48.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. F2 · balance_after: Includes 609.9221 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 08:49 UTC | Signify Health, Inc. SGFY · Entity 114996 | ConversionLLC Units in Cure Aggregator, LLC · Derivative | 1,260,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009921 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Long Dog, LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 1,260,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F1 · price: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F1 · derivative.exercise_date: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F1 · derivative.expiration_date: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F5 · ownership.nature: The Reporting Person serves as sole voting member and manager of the LLC. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 08:49 UTC | Signify Health, Inc. SGFY · Entity 114996 | Disposition to issuerClass A Common Stock | 1,260,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009921 · doc4.xml · nonDerivative · entry 4 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Long Dog, LLC Disclosed balance after: 0 F4 · kind: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration. F4 · price: Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration. F5 · ownership.nature: The Reporting Person serves as sole voting member and manager of the LLC. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 08:49 UTC | Signify Health, Inc. SGFY · Entity 114996 | Disposition to issuerClass B Common Stock | 1,260,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009921 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Long Dog, LLC Disclosed balance after: 0 F3 · kind: Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled. F3 · price: Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled. F5 · ownership.nature: The Reporting Person serves as sole voting member and manager of the LLC. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 08:49 UTC | Signify Health, Inc. SGFY · Entity 114996 | Disposition to issuerClass A Common Stock | 22,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009921 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · kind: Pursuant to the Merger Agreement, each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. F2 · price: Pursuant to the Merger Agreement, each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an "Issuer RSU"), that was (i) outstanding immediately prior to the effective time of the merger (the "Effective Time") to the extent vested and unsettled and (ii) any Issuer RSU that was outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer (each, a "Cash-Out RSU"), was cancelled and converted into the right to receive an amount in cash equal to (1) to $30.50 (the "Per Share Consideration") multiplied by (2) the number of shares of the Issuer's Class A Common Stock subject to such Cash-Out RSU. Read SEC document |
| March 29, 2023 Filed Mar 29, 2023 08:49 UTC | Signify Health, Inc. SGFY · Entity 114996 | ConversionClass A Common Stock | 1,260,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-009921 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Long Dog, LLC Disclosed balance after: 1,260,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F1 · price: On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. ("Parent") and Noah Merger Sub, Inc. (the "Merger Agreement"), an entity affiliated with the Reporting Person received 1,260,850 shares of the Issuer's Class A Common Stock ("Class A Common Stock") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC ("LLC Units") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock ("Class B Common Stock")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock. F5 · ownership.nature: The Reporting Person serves as sole voting member and manager of the LLC. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 20:39 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 3,792.876 | $60.64 | $230,000.00 |
DisclosureSEC source: 0000100493-23-000043 · wf-form4_167632077439557.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,561.1342 F1 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $230,000 granted and paid on the date of election as a director at the Annual Meeting of Shareholders held on February 9, 2023. F2 · balance_after: Includes 1,248.5865 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| May 19, 2022 Filed May 23, 2022 19:25 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass A Common Stock | 14,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-009030 · dp173664_4-mcnamara.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,588 F1 · shares: Represents a grant of restricted stock units on May 19, 2022 that will vest on the first anniversary of the grant date. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:38 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 2,758.48 | $97.88 | $270,000.02 |
DisclosureSEC source: 0000100493-22-000045 · wf-form4_164487828948259.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,689.4888 F1 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $270,000 granted and paid on the date of election as a director at the Annual Meeting of Shareholders held on February 10, 2022. F2 · balance_after: Includes 1,929.845 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| December 30, 2021 Filed Jul 26, 2022 19:43 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GiftClass A Common Stock | 6,279 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-22-000072 · wf-form4_165886456648480.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,519.6717 F1 · balance_after: Includes 1,109.1829 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 16:02 UTC | LUMINEX CORP LMNX · Entity 137318 | Disposition to issuerCommon Stock | 75,925 | $37.00 | $2,809,225.00 |
DisclosureSEC source: 0001033905-21-000062 · wf-form4_162637935002897.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · shares: Disposed of pursuant to the Merger Agreement, whereby unvested restricted stock units ("Company RSUs") which were outstanding as of immediately prior to the Effective Time fully vested, and each Company RSU that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes). Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 16:02 UTC | LUMINEX CORP LMNX · Entity 137318 | Disposition to issuerCommon Stock | 24,443 | $37.00 | $904,391.00 |
DisclosureSEC source: 0001033905-21-000062 · wf-form4_162637935002897.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,925 F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share. F2 · shares: This total includes 1,001 dividend shares acquired from the Reporting Person's brokerage Dividend Reinvestment Plan as follows: 782 shares corrected on 12/31/20, 87 shares on 01/14/21, 66 shares on 04/15/21, and 66 shares on 07/08/21. F3 · balance_after: This total includes 1,074 dividend equivalent shares acquired from the Issuer as follows: 180 shares on 07/09/20, 267 shares on 10/15/20, 244 shares on 01/14/21, 185 shares on 04/15/21, and 198 shares on 07/08/21. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 20:03 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass A Common Stock | 7,916 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-002446 · dp146249_4-mcnamara.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,916 F2 · shares: Represents a grant of restricted stock units on February 16, 2021 that will vest on the first anniversary of the grant date and settle on a deferred basis upon a separation from service. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 20:03 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantLLC Units in Cure Aggregator, LLC · Derivative | 230,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-002446 · dp146249_4-mcnamara.xml · derivative · entry 4 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,350 Underlying: Class A Common Stock · 230,350 shares Expires not disclosed F4 · derivative.exercise_price: The LLC Units are fully vested and may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. F1 · shares: These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC. F4 · derivative.exercise_date: The LLC Units are fully vested and may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. F4 · derivative.expiration_date: The LLC Units are fully vested and may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. F4 · derivative.underlying: The LLC Units are fully vested and may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 20:03 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantLLC Units in Cure Aggregator, LLC · Derivative | 1,030,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-002446 · dp146249_4-mcnamara.xml · derivative · entry 3 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030,500 Underlying: Class A Common Stock · 1,030,500 shares Expires not disclosed F3 · derivative.exercise_price: The LLC Units service-vested 75% on December 31, 2018, with the remaining 25% service-vesting in equal installments on each of January 1, 2020, 2021, 2022 and 2023, and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. F1 · shares: These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC. F3 · derivative.exercise_date: The LLC Units service-vested 75% on December 31, 2018, with the remaining 25% service-vesting in equal installments on each of January 1, 2020, 2021, 2022 and 2023, and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. F3 · derivative.expiration_date: The LLC Units service-vested 75% on December 31, 2018, with the remaining 25% service-vesting in equal installments on each of January 1, 2020, 2021, 2022 and 2023, and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. F3 · derivative.underlying: The LLC Units service-vested 75% on December 31, 2018, with the remaining 25% service-vesting in equal installments on each of January 1, 2020, 2021, 2022 and 2023, and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 20:03 UTC | Signify Health, Inc. SGFY · Entity 114996 | GrantClass B Common Stock | 1,260,850 | $0.01 | $12,608.50 |
DisclosureSEC source: 0000950103-21-002446 · dp146249_4-mcnamara.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260,850 F1 · shares: These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 18:25 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 4,132.231 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-21-000037 · wf-form4_161315434059106.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,001.2711 F1 · kind: Represents a stock award of deferred shares of the Issuer's Class A Common Stock having a value of $270,000 granted on the date of election as a director at the Annual Meeting of Shareholders held on February 11, 2021. Pursuant to the election made under the Deferred Stock Agreement for Directors, these deferred shares shall be settled and pay in five equal annual installments beginning 2 years after termination of the Reporting Person's service as a member of the Issuer's board of directors. F2 · balance_after: Includes 2,368.2345 shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 08:37 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 6,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-20-000073 · wf-form4_159136060804108.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,293 F1 · balance_after: This total includes 845 dividend shares acquired as follows: 173 shares on 07/11/19, 260 shares on 10/17/19, 226 shares on 01/15/20, and 186 shares on 04/09/20. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:52 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 3,384.731 | $79.77 | $269,999.99 |
DisclosureSEC source: 0000100493-20-000034 · wf-form4_158137152527199.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,500.8056 F3 · kind: Represents a stock award of deferred shares of the Issuer's Class A Common Stock having a value of $270,000 granted on the date of election as a director at the Annual Meeting of Shareholders held on February 6, 2020. Pursuant to the election made under the Deferred Stock Agreement for Directors, these deferred shares shall be settled and paid in five equal annual installments beginning 2 years after termination of the Reporting Person's service as a member of the Issuer's board of directors. F4 · balance_after: Includes 50,503.73 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall be settled and paid 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors and 3,384.731 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Stock Agreement for Directors, which shares shall be settled and paid in five equal annual installments beginning 2 years after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| December 17, 2019 Filed Feb 10, 2020 21:52 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 1,540.1544 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-20-000034 · wf-form4_158137152527199.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,116.0746 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 50,503.73 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall be settled and paid 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| May 17, 2019 Filed May 20, 2019 18:38 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 9,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-19-000050 · wf-form4_155839186805120.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,165 F1 · balance_after: This total includes 459 dividend shares acquired as follows: 94 shares on 07/13/18, 112 shares on 10/12/18, 123 shares on 01/10/19, and 130 shares on 04/11/19. Read SEC document |
| February 07, 2019 Filed Feb 11, 2019 16:30 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 2,661.344 | $60.12 | $160,000.00 |
DisclosureSEC source: 0000100493-19-000030 · wf-form4_154990263342879.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,575.9202 F3 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $160,000 granted on the date of election as a director at the Annual Meeting of Shareholders held on February 7, 2019. Per the Deferred Fee Plan for Directors, these shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. F4 · balance_after: Includes 49,534.979 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| December 17, 2018 Filed Feb 11, 2019 16:30 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 508.8307 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-19-000030 · wf-form4_154990263342879.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,914.5762 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 46,873.635 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 17:02 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 444.6891 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-18-000128 · wf-form4_154281973791410.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,227.9012 F3 · kind: Shares acquired pursuant to the Issuer's Director Compensation Policy which permits Directors of the Issuer to elect to receive shares of the Issuer's Class A Common Stock in lieu of receiving all or part of their quarterly retainer in cash. F2 · balance_after: Includes 46,561.0617 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| November 19, 2018 Filed Nov 28, 2018 15:13 UTC Amendment | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 444.6891 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-18-000136 · wf-form4a_154341796655105.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,405.7455 F3 · kind: Shares acquired pursuant to the Issuer's Director Compensation Policy which permits Directors of the Issuer to elect to receive shares of the Issuer's Class A Common Stock in lieu of receiving all or part of their quarterly retainer in cash. F2 · balance_after: Includes 46,561.063 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| September 18, 2018 Filed Nov 21, 2018 17:02 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 961.4635 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-18-000128 · wf-form4_154281973791410.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,783.2121 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 46,561.0617 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| September 18, 2018 Filed Nov 28, 2018 15:13 UTC Amendment | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 988.8025 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-18-000136 · wf-form4a_154341796655105.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,961.0564 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 46,561.063 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| May 17, 2018 Filed Jun 1, 2018 18:28 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 7,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-18-000071 · wf-form4_152789206996604.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,470 F1 · balance_after: This total includes 127 dividend shares from 07/14/17, 128 dividend shares from 10/13/17, 127 dividend shares from 01/12/18, 121 dividend shares from 04/13/18 and a grant of 7,464 shares on 05/17/18. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 19:13 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 338.203 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-18-000033 · wf-form4_151846277553725.xml · nonDerivative · entry 3 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,824.6476 F4 · kind: Shares acquired pursuant to the Issuer's Director Compensation Policy which permits Directors of the Issuer to elect to receive shares of the Issuer's Class A Common Stock in lieu of receiving all or part of their quarterly retainer in cash. F2 · balance_after: Includes 45,961.877 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 19:13 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 2,029.221 | $73.92 | $150,000.02 |
DisclosureSEC source: 0000100493-18-000033 · wf-form4_151846277553725.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,486.4446 F3 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $150,000 granted on the date of election as a director at the Annual Meeting of Shareholders held on February 8, 2018. Per the Issuer's Director Compensation Policy, the Reporting Person elected to take this stock award in lieu of a deferred stock award otherwise granted to the Issuer's non-employee directors. F2 · balance_after: Includes 45,961.877 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| December 18, 2017 Filed Feb 12, 2018 19:13 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 169.517 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-18-000033 · wf-form4_151846277553725.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,457.2236 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 45,961.877 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 20:59 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 388.299 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-17-000137 · wf-form4_151095233541542.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,287.7066 F3 · kind: Shares acquired pursuant to the Issuer's Director Compensation Policy which permits Directors of the Issuer to elect to receive shares of the Issuer's Class A Common Stock in lieu of receiving all or part of their quarterly retainer in cash. F2 · balance_after: Includes 45,792.3607 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| September 19, 2017 Filed Nov 17, 2017 20:59 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 798.5727 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-17-000137 · wf-form4_151095233541542.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,899.4076 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 45,792.3607 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| May 19, 2017 Filed May 22, 2017 15:10 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 6,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-17-000058 · wf-form4_149548021797549.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,503 F1 · balance_after: This total includes 124 dividend shares from April 14, 2017 payable date and a grant of 6,105 shares on May 18,2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 13:54 UTC | TYSON FOODS, INC. TSN · Entity 3273 | PurchaseClass A Common Stock | 350 | $65.27 | $22,845.41 |
DisclosureSEC source: 0000100493-17-000039 · wf-form4_148716685787380.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,100.8349 F1 · balance_after: Includes 45,312.2407 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 22:50 UTC | TYSON FOODS, INC. TSN · Entity 3273 | GrantClass A Common Stock | 2,293.929 | $65.39 | $150,000.02 |
DisclosureSEC source: 0000100493-17-000027 · wf-form4_148676700401474.xml · nonDerivative · entry 2 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,750.8349 F3 · kind: Represents a stock award for shares of the Issuer's Class A Common Stock having a value of $150,000 granted on the date of election as a director at the Annual Meeting of Shareholders held on February 9, 2017. F2 · balance_after: Includes 45,312.2407 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| December 19, 2016 Filed Feb 10, 2017 22:50 UTC | TYSON FOODS, INC. TSN · Entity 3273 | OtherClass A Common Stock | 529.1949 | $0.00 | $0.00 |
DisclosureSEC source: 0000100493-17-000027 · wf-form4_148676700401474.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,456.9059 F1 · kind: Represents shares of the Issuer's Class A Common Stock received by the Reporting Person pursuant to the Issuer's dividend reinvestment plan since the last Statement of Changes in Beneficial Ownership was filed by the Reporting Person. Such acquisitions are exempt from Section 16 concurrent reporting requirements pursuant to Rule 16a-11. F2 · balance_after: Includes 45,312.2407 shares of the Issuer's Class A Common Stock acquired by the Reporting Person pursuant to the Deferred Fee Plan for Directors, which shares shall vest 180 days after termination of the Reporting Person's service as a member of the Issuer's board of directors. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 10:35 UTC | LUMINEX CORP LMNX · Entity 137318 | SaleCommon Stock | 12,000 | $21.03 | $252,411.60 |
DisclosureSEC source: 0001033905-16-000200 · wf-form4_147931050220295.xml · nonDerivative · entry 1 MCNAMARA KEVIN M · CIK 0001200996 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,274 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.13 inclusive. Mr. McNamara undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.